Scientific studies & consumer anecdotes about healthier living by reversing NAD+ decline (for information purposes only)

Month: September 2024

What’s the Case for Niagen+ IVs (NR IVs) Over NAD+ IVs?

While we mostly focus here on oral vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews), there’s growing demand for raising NAD levels through NAD+ IVs. And, if you enjoy NAD+ IVs, you now have an alternative: Niagen+ IVs, which deliver NAD+ booster Nicotinamide Riboside “NR”. Whats the case for Niagen+ IVs over NAD+ IVs? Here’s how Chromadex CEO Rob Fried (seller of NR brand Niagen) explained it at an August investor conference:

Anecdote #37: “This (NR) has definitely made a difference in my energy levels”

As we await clinical trial results to confirm individual claims about NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews), we’re always interested to see if there are any consistencies in consumer anecdotal reports. Today, we hear from Coach Beede who posted the following earlier today (reposted here with permission):

Anecdote #36: Nicotinamide Riboside (NR) Cleared Mild Psoriasis

In response to yesterday’s Anecdote #35: “I’ve noticed…a dramatic reduction in my psoriasis” (Link), my friend Jeff Gilligan commented that he too enjoyed a similar experience after taking NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Here’s what he said:

Anecdote #35: “I’ve Noticed…a Dramatic Reduction in My Psoriasis”

This is not the first time we’ve heard from someone claiming that vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) helped treat psoriasis. Gary Varvaro told us the same (Link). Some might find these claims plausible considering we’ve also heard from many others reporting remarkable skin benefits after taking NR  (Link). Of course, until we have positive results from human clinical trials, we won’t know whether these claims have any credibility. That said, here is yet another powerful personal experience submitted to us by NR consumer Lawrence Lane:

What Explains the Delay in Releasing Results of the NR / Long COVID Clinical Study?

We all know someone suffering from Long COVID. And, if you’re like me, you’ve been waiting patiently for results of the Harvard/MGH Long COVID clinical study (Details) evaluating NAD+ boosting supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes) as a possible treatment. So, what’s the status of the study? Chromadex CEO Rob Fried explained during an investor presentation at the end of August:

Powered by WordPress & Theme by Anders Norén